BioMaxima S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
For the nine months, sales was PLN 33.44 million compared to PLN 130.52 million a year ago. Net income was PLN 0.493 million compared to PLN 28.57 million a year ago. Basic earnings per share from continuing operations was PLN 0.11 compared to PLN 6.6 a year ago. Diluted earnings per share from continuing operations was PLN 0.11 compared to PLN 6.41 a year ago.